Company Dottikon ES Holding AG

DESN

CH0582581713

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 11:31:27 2025-06-20 am EDT			5-day change	1st Jan Change
285.50 ^CHF	-1.72%		-0.52%	+29.19%

May. 28	Swiss Market Index Retreats; Dottikon ES Shares Soar	MT
May. 28	Swiss Chemicals Group Dottikon Surges 16% as Fiscal 2025 Profit Jumps Amid Capacity Boost	MT

Business description: Dottikon ES Holding AG

Dottikon ES Holding AG is a Switzerland-based holding company that specializes in hazardous chemistry and focuses on the exclusive synthesis of fine chemicals for the pharmaceutical and chemical industries. Its product range includes active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, as well as industrial chemicals. Its pharmaceutical products can be found in medications for, among others, heart disease, asthma, high blood pressure and ulcers. Dottikon ES Holding AG's industrial end products include food additives, cosmetics, electro-chemicals, photo-chemicals and agricultural chemicals. The Company also offers distillation plants and thin layer evaporators for the recycling of solvents, as well as high temperature incinerators for the waste treatment of hazardous waste. As of March 31, 2012, the Company had two wholly owned subsidiaries: DOTTIKON EXCLUSIVE SYNTHESIS AG and DOTTIKON ES MANAGEMENT AG. It also held a 33.9%-stake in SYSTAG, System Technik AG.

Number of employees: 793

Sales by Activity: Dottikon ES Holding AG

Fiscal Period: March	2021	2022	2023	2024	2025
Chemicals	219M	252M	319M	333M	393M

See all business segments

Executive Committee: Dottikon ES Holding AG

Manager	Title	Age	Since
Markus Blocher CEO	Chief Executive Officer	54	2002-12-31
Marlene Born DFI	Director of Finance/CFO	50	2005-12-31
Urs Brändli CTO	Chief Tech/Sci/R&D Officer	65	2002-12-31
Karin Krause HRO	Human Resources Officer	57	2014-12-31
Stephan Kirschbaum PRN	Corporate Officer/Principal	58	2008-12-31

See DOTTIKON ES HOLDING AG governance

Composition of the Board of Directors: Dottikon ES Holding AG

Director	Title	Age	Since
Markus Blocher CHM	Chairman	54	2011-12-31
Alfred Scheidegger BRD	Director/Board Member	68	2011-06-30
Bernhard Urwyler BRD	Director/Board Member	67	2020-07-02

Composition of the Board of Directors

Shareholders: Dottikon ES Holding AG

Name	Equities	%	Valuation
Markus Blocher 64.74 %	9,062,931	64.74 %	3 050 M CHF
Estate Of Grogg Peter 7 %	979,936	7 %	330 M CHF
Blocher Miriam Baumann 5.107 %	715,000	5.107 %	241 M CHF
UBS Asset Management Switzerland AG 4.182 %	585,420	4.182 %	197 M CHF
VV Vermögensverwaltung AG 1.547 %	216,600	1.547 %	73 M CHF

List of DOTTIKON ES HOLDING AG shareholders

Company details: Dottikon ES Holding AG

Dottikon ES Holding AG

Hembrunnstrasse 17

5605, Dottikon

+41 56 616 81 11

http://www.dottikon.com

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
DOTTIKON ES HOLDING AG	-1.72%	-0.52%	+10.44%	+31.57%	4.83B
ELI LILLY AND COMPANY	-2.84%	-6.91%	-13.71%	+156.52%	685B
JOHNSON & JOHNSON	-0.62%	-4.65%	+0.70%	-13.42%	360B
ABBVIE INC.	-0.10%	-3.02%	+8.75%	+29.16%	327B
NOVO NORDISK A/S	-2.58%	-7.83%	-51.84%	+25.00%	326B
ROCHE HOLDING AG	-0.27%	-3.86%	+2.57%	-13.95%	255B
NOVARTIS AG	-0.34%	-2.34%	+0.96%	+20.36%	228B
ASTRAZENECA PLC	-1.52%	-5.41%	-16.68%	+2.61%	217B
MERCK & CO., INC.	-0.29%	-3.24%	-39.52%	-10.19%	199B
AMGEN INC.	-0.10%	-2.00%	-6.11%	+21.36%	156B
Average	-1.04%	-3.81%	-10.44%	+24.90%	275.68B
Weighted average by Cap.	-1.31%	-4.71%	-12.58%	+44.66%